HomeInsights52 Week Low Stocks

Kabra Drugs Ltd 52 Week Low

Kabra Drugs Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 9, 2024)

stocks purchased

2.4 K

Stocks Traded

(Dec 9, 2024)

Last Updated on: Dec 12, 2024

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

YEARLOW

₹ 4.9

Last updated on: Dec 09, 2024

Key Highlights

  • The 52 Week Low of Kabra Drugs Ltd is ₹ 4.9 as of 09 Dec 24 .

Company Fundamentals for Kabra Drugs Ltd

No data available

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Dec 20249.59
02 Dec 20249.59
25 Nov 20249.59
18 Nov 20249.59
11 Nov 20249.59
04 Nov 20249.14
28 Oct 20249.14
21 Oct 20249.14
14 Oct 20249.14
07 Oct 20249.14

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Kabra Drugs Ltd News Hub

News

Kabra Drugs to conduct EGM

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be ...

Read more

05 Dec 2024 17:27

News

Kabra Drugs schedules board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 202...

Read more

26 Nov 2024 09:56

News

Kabra Drugs to convene board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 20...

Read more

08 Nov 2024 12:27

News

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 202...

Read more

22 Oct 2024 11:01

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 2024 09:56

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 20...

Read more

28 Aug 2024 14:54

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Kabra Drugs Ltd

Why is it important to track the 52-week low of Kabra Drugs Ltd stocks?

Investors should monitor the 52-week low of Kabra Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Kabra Drugs Ltd stocks hitting a 52-week low?

Factors leading to Kabra Drugs Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Kabra Drugs Ltd stocks when they hit a 52-week low?

Buying Kabra Drugs Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Kabra Drugs Ltd stocks?

Investors should monitor the 52-week low of Kabra Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Kabra Drugs Ltd stock at their 52-week low?

An investor can analyze the reasons for the Kabra Drugs Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Kabra Drugs Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Kabra Drugs Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Kabra Drugs Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions